A comparative analysis of the efficacy and safety of therapeutic interventions in phlegmasia cerulea dolens.
Document Type
Article
Publication Date
6-1-2021
Publication Title
Phlebology
Abstract
OBJECTIVE: Present an institution's experience in management of phlegmasia cerulea dolens (PCD) with a review of the literature.
METHODS: Beaumont Health's electronic record database was queried between July 2009 and November 2019 for inpatients with PCD. A comprehensive chart review was performed to verify the accuracy of the diagnosis and extract relevant parameters. Medians and proportions are reported.
RESULTS: 22 patients met the criteria for PCD. 59% females. Median age 65 years (interquartile range [IQR] 22). Obesity was present in 45% of patients. 18 patients underwent either a single modality (55.5%) or a multimodality therapeutic approach (44.5%). Limb amputation was required in a third of patients who underwent catheter-directed thrombolysis or percutaneous thrombectomy alone. Death was highest after percutaneous thrombectomy alone (66%) followed by pharmacomechanical catheter-directed thrombolysis alone (50%).
CONCLUSION: Percutaneous interventions have become the mainstay in management of PCD as demonstrated in this large retrospective analysis and supported by literature review.
Volume
36
Issue
5
First Page
392
Last Page
400
Recommended Citation
Said A, Sahlieh A, Sayed L. A comparative analysis of the efficacy and safety of therapeutic interventions in phlegmasia cerulea dolens. Phlebology. 2021 Jun;36(5):392-400. doi: 10.1177/0268355520975581. Epub 2020 Nov 25. PMID: 33236674.
DOI
10.1177/0268355520975581
ISSN
1758-1125
PubMed ID
33236674